AN301817L
Recombinant SUV39H2 Monoclonal Antibody
Size
£252.90
Was £281.00
- SKU:
- AN301817L
- Additional Names:
- SUV39H,SUV39H2,KMT1B,FLJ23414,H3 K9 HMTase 2,H3-K9-HMTase 2,Histone H3 K9 methyltransferase 2,Histone H3-K9 methyltransferase 2,Histone lysine N methyltransferase H3 lysine 9 specific 2,Histone lysine N methyltransferase SUV39H2,Histone-lysine N-methyltransferase SUV39H2,Lysine N methyltransferase 1B,Lysine N-methyltransferase 1B,sSuppressor of variegation 3 9 homolog 2 (Drosophila),Su(var)3 9 Drosophila homolog of 2,Su(var)3 9 homolog 2,Su(var)3-9 homolog 2,Suppressor of variegation 3 9
- Application:
- IHC, WB
- Concentration:
- 1 mg/ml
- Purification:
- Protein A Purified
- Storage Conditions:
- -20[o]C Avoid freeze/thaw cycles.
- Supplier:
- Elabscience
- Host:
- Rabbit
- Reactivities:
- Human, Mouse, Rat
- Buffer:
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
- Immunogen:
- Recombinant human SUV39H2 fragment
- Clone:
- A529
- Uniprot:
- Q9H5I1
- Synonyms:
- H3-K9-HMTase 2;histone H3-K9 methyltransferase 2;histone methyltransferase SUV39H2;histone-lysine N-methyltransferase SUV39H2;KMT1B;lysine N-methyltransferase 1B;su(var)3-9 homolog 2;suppressor of variegation 3-9 homolog 2
- Extra Details:
- SUV39H2, also known as KMT1B, is a member of the SUV39 subfamily of lysine methyltransferases (KMTs) that plays a significant role in histone H3-K9 di-/Trimethylation, transcriptional regulation and cell cycle. Overexpressions of SUV39H2 at gene, mRNA and protein levels are known to be associated with a range of cancers: leukemia, lymphomas, lung cancer, breast cancer, colorectal cancer, gastric cancer, hepatocellular cancer and so on. Accumulating evidence indicates that SUV39H2 acts as an oncogene and contributes to the initiation and progression of cancers.
- Shipping Conditions:
- Blue Ice